Drugs/Medical Legal News Articles & Interviews

Santa Clara, CA June 2024 marks the two-year anniversary of Suboxone’s statute of limitations deadlines and lawyers predict thousands more Suboxone tooth decay lawsuits will be filed against Indivior Inc., mainly failure to warn about the risk of dental injuries. It is crucial to file a lawsuit against Indivior or other defendants before the statute of limitations passes. If not, plaintiffs may be unable to proceed with a case.

Los Angeles, CA Patients who have undergone surgeries and endoscopies and taking weight-loss Ozempic, Wegovy and other GLP-1 medications risk aspiration pneumonia. A study conducted by researchers in California found that patients who underwent the procedure were 33 percent more likely to suffer the complication, which can be life-threatening.

Santa Clara, CA Philips Respironics has agreed to settle over 700 lawsuits for $1.1 billion. Since the massive 2021 recall of its faulty breathing machines and ventilators that released toxic and carcinogenic fumes into customers’ mouths, throats and lungs, more than 50,000 people have been involved in the litigation.

Silver Spring, MD On January 3, 2024, the U.S. Food and Drug Administration (FDA) issued an updated advisory to medical professionals warning them not to purchase or implant, and to remove from their inventory all Synovo Total Hip Systems because the devices have been substantially modified since their initial 1991 approval. The gathering storm of Synovo hip failure lawsuits is only a part of the larger picture of hip implant litigation that now also involves devices manufactured by Exactech, Smith & Nephew, Stryker, and Zimmer.

Santa Clara, CA U.S. District Judge David G. Campbell has said that the Bard PowerPort lawsuit selections will go ahead as scheduled, despite the manufacturer arguing to delay the bellwether process. Judge Campbell is presiding over all Bard PowerPort fracture and migration lawsuits filed in federal courts nationwide.

Santa Clara, CA Women on birth control or presumed to be infertile have been reporting surprise pregnancies while on Ozempic and similar medications. Referred to as “Ozempic Babies”, they add to increasing concern over the side effects of these diabetes and weight-loss drugs. Healthcare professionals, seeing an association between these medications and unexpected pregnancy on birth control, are warning that these drugs may decrease the effectiveness of oral contraception.

Brooklyn, NY As of March 2024, 1,244 defective, ankle, knee and hip implant lawsuits were pending in multidistrict litigation in the Eastern District of New York. Although no trials or settlements have yet occurred, some speculate that individual hip plaintiffs may ultimately expect to recover as much as $300,000.

Philadelphia, PA Fifty-five Ozempic and similar weight loss drug lawsuits have been centralized in Eastern Pennsylvania, with U.S. District Judge Gene E.K. Pratter at the helm of the MDL and scheduled to commence March 14 at the first status conference. The litigation claims that Novo Nordisk's Ozempic, Wegovy and Rybelsus and Eli Lilly's Mounjaro and Trulicity cause gastroparesis and other serious gastrointestinal injuries, and the companies failed to warn patients about the risks associated with GLP-1 receptor agonist medications.

New York, NY As the demand for Ozempic and other semaglutide weight-loss drugs increases, more serious side effects such as stomach paralysis are being reported to medical professionals, the FDA, and attorneys.

Evanston, IL NorthShore University Health System has agreed to pay $55 million to settle a federal consumer class action lawsuit that was filed back in 2007. The settlement ends 16 years of litigation over its merger with another hospital that allegedly allowed NorthShore to illegally monopolize the market and unfairly raise prices on patients.